We also found that activation of AKT1 independently influenced patients’ survival, with higher expression of p-AKT1 being linked to poorer OS; neither EGFR nor p-EGFR expression, however, had a prognostic effect in ESCC patients in this cohort. Here, EGFR is linked to esophageal squamous cell carcinoma.